https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Video-MC.jpg

Surgical Robotics Systems Market Analysis | China | 2017-2023 | MedCore

  • Year: 2017
  • Scope: 2013-2023
  • Region: China
  • Pages: 579
  • Published Date: 2/1/2017
  • Type: MedCore

The development of robotics in neurosurgery was a result of neurosurgeons reaching their surgical boundaries based on traditional methods. The scale of surgery has become so small that even with the aid of image guidance, intraoperative imaging and microscopy, the natural dexterity of surgeons creates limits. Neurosurgery was one of the first fields of medicine in which robotic assisted systems were designed.

Surgical robotics has tremendous potential to increase the effectiveness of existing procedures and to facilitate novel procedure types. The surgical robotics industry is, in many ways, still in its infancy, with more products in development than currently commercially available on the market. Most new surgical robotic systems are designed for highly specialized medical applications, which is a major draw-back for most facilities.

Segments Covered in This Market

  • Robotic Assisted Surgery System Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

The ROSA™ is robotic device designed for usage in neurosurgical procedures. Currently it is the only robotic assistant approved for neurosurgical clinical use in Europe, the United States and China. The robotic arm associated with the ROSA™ offers six degrees of freedom and provides haptic capabilities to the neurosurgeon. It has capabilities to perform DBS, electrodes, implantation, biopsies, endoscopy and other keyhole procedures.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled China Market Report Suite for Surgical Navigation and Robotics Systems – MedSuite

Learn More about these product types
 

FREE Sample Report

TABLE OF CONTENTS I
LIST OF FIGURES XXI
LIST OF CHARTS XXVI
EXECUTIVE SUMMARY 1
CHINA ROBOTICS AND SURGICAL NAVIGATION MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
MARKETS INCLUDED 8
KEY REPORT UPDATES 9
VERSION HISTORY 9
RESEARCH METHODOLOGY 10
1.1 RESEARCH SCOPE 10
1.2 IDATA’S 9-STEP METHODOLOGY 10
Step 1: Project Initiation & Team Selection 10
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 13
Step 4: Performing Primary Research 14
Step 5: Research Analysis: Establishing Baseline Estimates 16
Step 6: Market Forecast and Analysis 17
Step 7: Identify Strategic Opportunities 19
Step 8: Final Review and Market Release 20
Step 9: Customer Feedback and Market Monitoring 21
DISEASE OVERVIEW 22
2.1 MEDICAL CONDITIONS 22
2.1.1 Neurosurgery Conditions 22
2.1.1.1 Hydrocephalus 22
2.1.1.2 Communicating Hydrocephalus 22
2.1.1.3 Normal Pressure Hydrocephalus 23
2.1.1.4 Non-Communicating Hydrocephalus 23
2.1.1.5 Brain Tumor 23
2.1.1.6 Intracranial Pressure 23
2.1.1.7 Intracranial Aneurysm 23
2.1.1.8 Intracranial Atherosclerosis Disease 23
2.1.2 Spinal Conditions 25
2.1.2.1 Herniated Disc 25
2.1.2.2 Spinal Stenosis 25
2.1.2.3 Spondylosis 25
2.1.2.4 Scoliosis 25
2.1.2.5 Lordosis 25
2.1.2.6 Kyphosis 26
2.1.3 ENT Conditions 27
2.1.3.1 Otitis Media 27
2.1.3.2 Cholesteatomas 27
2.1.3.3 Otosclerosis 27
2.1.3.4 Chronic Sinusitis 27
2.1.3.5 Tonsillitis 27
2.1.4 Orthopedic Conditions 28
2.1.4.1 Fractures 28
2.1.4.2 Osteoporosis 28
2.1.4.3 Arthritis 28
2.1.5 Gynecological Conditions 28
2.1.5.1 Gynecological Cancers 28
2.1.5.2 Uterine Fibroids 29
2.1.5.3 Endometriosis 29
2.1.5.4 Menorrhagia 29
2.1.5.5 Pelvic Prolapse 29
2.1.6 Urological Conditions 31
2.1.6.1 Prostate Cancer 31
2.1.6.2 Bladder Cancer 31
2.1.6.3 Kidney Cancer 31
2.1.6.4 Benign Prostate Hyperplasia (BPH) 32
2.1.7 Digestive Tract Conditions 33
2.1.7.1 Achalasia 33
2.1.7.2 Stomach Cancer 33
2.1.7.3 Hernia 33
2.1.7.4 Gallbladder Attack 33
2.1.7.5 Gastroesophageal Reflex Disease 34
2.1.8 Colorectal Conditions 35
2.1.8.1 Colorectal Cancer 35
2.1.8.2 Inflammatory Bowel Disease 35
2.1.8.3 Diverticulitis 35
2.1.9 Cardiac Conditions 37
2.1.9.1 Mitral Valve Prolapse 37
2.1.9.2 Coronary Artery Disease 37
PRODUCT ASSESSMENT 38
3.1 ROBOTIC ASSISTED SURGERY PRODUCT PORTFOLIOS 38
3.1.1 Robotic-Assisted Surgery Overview 38
3.1.2 Neurosurgery 39
3.1.3 Spine Surgery 41
3.1.4 Orthopedic Surgery 42
3.2 RAS REGULATORY ISSUES AND RECALLS 44
3.2.1 Accuray Inc. 44
3.2.2 Blue Belt Technologies 46
3.2.3 Hansen Medical Inc. 47
3.2.4 Intuitive Surgical 48
3.2.5 MAKO Surgical/Stryker 67
3.2.6 OMNIlife Science 69
3.3 CLINICAL TRIALS 71
3.4 RAS CLINICAL TRIALS 72
3.4.1 Accuray Inc. 72
3.4.2 Catheter Precision 78
3.4.3 Corindus Inc 80
3.4.4 Hansen Medical 82
3.4.5 Intuitive Surgical 83
3.4.6 MAKO Surgical/Stryker 86
3.4.7 Mazor 89
3.4.8 Medrobotics 92
3.4.9 Medtech 93
SURGICAL ROBOTICS MARKET 94
4.1 INTRODUCTION 94
4.2 NEUROSURGERY ROBOTIC ASSISTED SURGERY SYSTEM MARKET 96
4.2.1 Introduction 96
4.2.2 Market Analysis and Forecast 96
4.2.3 Drivers and Limiters 101
4.2.3.1 Market Drivers 101
4.2.3.2 Market Limiters 101
4.2.4 Leading Competitors 103
4.2.5 Emerging Competitors 105
4.3 MINIMALLY INVASIVE SURGERY ROBOTIC DEVICE MARKET 106
4.3.1 Introduction 106
4.3.2 Market Analysis and Forecast 107
4.3.3 Drivers and Limiters 111
4.3.3.1 Market Drivers 111
4.3.3.2 Market Limiters 111
4.3.4 Emerging Competitors 113
4.4 ROBOTIC RADIOSURGERY DEVICE MARKET 114
4.4.1 Introduction 114
4.4.2 Market Analysis and Forecast 115
4.4.3 Drivers and Limiters 119
4.4.3.1 Market Drivers 119
4.4.3.2 Market Limiters 120
4.4.4 Leading Competitors 122
4.5 ROBOTIC ASSISTED SPINAL SURGERY MARKET (APPENDIX) 123
4.5.1 Introduction 123
4.5.2 Market Analysis and Forecast 123
4.5.3 Drivers and Limiters 124
4.5.3.1 Market Drivers 124
4.5.3.2 Market Limiters 125
4.5.4 Leading Competitors 127
4.5.5 Emerging Competitors 128
ABBREVIATIONS 129
APPENDIX: COMPETITOR PRESS RELEASES 131
The "China Market Report Suite for Surgical Navigation and Robotics Systems 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Brainlab
Medtronic
Stryker
Karl Storz
Medtech Surgical
Mazor Robotics
Intuitive Surgical
Accuray
Hansen Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.
Chart 1 1: Robotics and Surgical Navigation Market by Segment, China, 2013 – 2023 2
Chart 1 2: Robotics and Surgical Navigation Market Overview, China, 2016 & 2023 3
Chart 4 1: Neurosurgery Robotic Assisted Surgery System Market, China, 2013 – 2023 100
Chart 4 2: Minimally Invasive Surgery Robotic Device Market, China, 2013 – 2023 110
Chart 4 3: Robotic Radiosurgery Device Market, U.S., 2013 – 2023 118

Figure 1 1: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, China, 2016 (1 of 2) 4
Figure 1 2: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, China, 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, China, 2016 5
Figure 1 4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, China 6
Figure 1 5: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, China (2 of 2) 7
Figure 1 6: Recent Events in the Robotics and Surgical Navigation Market, China, 2013 – 2016 8
Figure 1 7: Robotics and Surgical Navigation Markets Covered, China, 2016 8
Figure 1 8: Key Report Updates 9
Figure 1 9: Version History 9
Figure 3 1: Robot-Assisted Neurosurgery Products by Company 40
Figure 3 2: Robot-Assisted Spine Surgery Products by Company 41
Figure 3 3: Robot-Assisted Orthopedic Surgery Products by Company 43
Figure 3 4: Class 2 Device Recall Accuray Inc 44
Figure 3 5: Class 2 Device Recall Accuray Inc 44
Figure 3 6: Class 2 Device Recall Accuray Inc 44
Figure 3 7: Class 2 Device Recall Accuray Inc 45
Figure 3 8: Class 2 Device Recall Accuray Inc 45
Figure 3 9: Class 2 Device Recall Accuray Inc 45
Figure 3 10: Class 2 Device Recall Blue Belt Technologies 46
Figure 3 11: Class 2 Device Recall Blue Belt Technologies 46
Figure 3 12: Class 2 Device Recall Blue Belt Technologies 46
Figure 3 13: Class 2 Device Recall Hansen Medical 47
Figure 3 14: Class 2 Device Recall Hansen Medical 47
Figure 3 15: Class 2 Device Recall Hansen Medical 47
Figure 3 16: Class 2 Device Recall Intuitive Surgical 48
Figure 3 17: Class 2 Device Recall Intuitive Surgical 48
Figure 3 18: Class 2 Device Recall Intuitive Surgical 48
Figure 3 19: Class 2 Device Recall Intuitive Surgical 49
Figure 3 20: Class 2 Device Recall Intuitive Surgical 49
Figure 3 21: Class 2 Device Recall Intuitive Surgical 49
Figure 3 22: Class 2 Device Recall Intuitive Surgical 50
Figure 3 23: Class 2 Device Recall Intuitive Surgical 50
Figure 3 24: Class 2 Device Recall Intuitive Surgical 51
Figure 3 25: Class 2 Device Recall Intuitive Surgical 51
Figure 3 26: Class 2 Device Recall Intuitive Surgical 52
Figure 3 27: Class 2 Device Recall Intuitive Surgical 53
Figure 3 28: Class 2 Device Recall Intuitive Surgical 53
Figure 3 29: Class 2 Device Recall Intuitive Surgical 53
Figure 3 30: Class 2 Device Recall Intuitive Surgical 54
Figure 3 31: Class 2 Device Recall Intuitive Surgical 54
Figure 3 32: Class 2 Device Recall Intuitive Surgical 55
Figure 3 33: Class 2 Device Recall Intuitive Surgical 55
Figure 3 34: Class 2 Device Recall Intuitive Surgical 55
Figure 3 35: Class 2 Device Recall Intuitive Surgical 56
Figure 3 36: Class 2 Device Recall Intuitive Surgical 56
Figure 3 37: Class 2 Device Recall Intuitive Surgical 56
Figure 3 38: Class 2 Device Recall Intuitive Surgical 57
Figure 3 39: Class 2 Device Recall Intuitive Surgical 57
Figure 3 40: Class 2 Device Recall Intuitive Surgical 58
Figure 3 41: Class 2 Device Recall Intuitive Surgical 59
Figure 3 42: Class 2 Device Recall Intuitive Surgical 59
Figure 3 43: Class 2 Device Recall Intuitive Surgical 60
Figure 3 44: Class 2 Device Recall Intuitive Surgical 60
Figure 3 45: Class 2 Device Recall Intuitive Surgical 61
Figure 3 46: Class 2 Device Recall Intuitive Surgical 61
Figure 3 47: Class 2 Device Recall Intuitive Surgical 61
Figure 3 48: Class 2 Device Recall Intuitive Surgical 62
Figure 3 49: Class 2 Device Recall Intuitive Surgical 62
Figure 3 50: Class 2 Device Recall Intuitive Surgical 62
Figure 3 51: Class 2 Device Recall Intuitive Surgical 63
Figure 3 52: Class 2 Device Recall Intuitive Surgical 63
Figure 3 53: Class 2 Device Recall Intuitive Surgical 63
Figure 3 54: Class 2 Device Recall Intuitive Surgical 64
Figure 3 55: Class 2 Device Recall Intuitive Surgical 64
Figure 3 56: Class 2 Device Recall Intuitive Surgical 64
Figure 3 57: Class 2 Device Recall Intuitive Surgical 64
Figure 3 58: Class 2 Device Recall Intuitive Surgical 65
Figure 3 59: Class 2 Device Recall Intuitive Surgical 65
Figure 3 60: Class 2 Device Recall Intuitive Surgical 65
Figure 3 61: Class 2 Device Recall MAKO Surgical/Stryker 67
Figure 3 62: Class 2 Device Recall MAKO Surgical/Stryker 67
Figure 3 63: Class 2 Device Recall MAKO Surgical/Stryker 67
Figure 3 64: Class 2 Device Recall MAKO Surgical/Stryker 68
Figure 3 65: Class 2 Device Recall MAKO Surgical/Stryker 68
Figure 3 66: Class 2 Device Recall MAKO Surgical/Stryker 68
Figure 3 67: Class 2 Device Recall OMNIlife Science, Inc 69
Figure 3 68: Class 2 Device Recall OMNIlife Science, Inc 69
Figure 3 69: Class 2 Device Recall OMNIlife Science, Inc 69
Figure 3 70: Class 2 Device Recall OMNIlife Science, Inc 70
Figure 3 71: Class 2 Device Recall OMNIlife Science, Inc 70
Figure 3 72: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer 72
Figure 3 73: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer 72
Figure 3 74: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors 73
Figure 3 75: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients 73
Figure 3 76: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors 74
Figure 3 77: Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer 74
Figure 3 78: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease 75
Figure 3 79: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI) 75
Figure 3 80: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy 76
Figure 3 81: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer 76
Figure 3 82: Stereotactic Radiosurgery for Soft Tissue Sarcoma 77
Figure 3 83: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma 77
Figure 3 84: Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System 78
Figure 3 85: Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid Isthmus 78
Figure 3 86: Manual vs Amigo SmartTouch Atrial Fibrillation Study (MAST-AF) 79
Figure 3 87: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID) 80
Figure 3 88: Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II) 80
Figure 3 89: Post-Market CorPath Registry on the CorPath 200 System 81
Figure 3 90: Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System 82
Figure 3 91: Registry of the Magellan Robotic System (ROVER) 82
Figure 3 92: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair 83
Figure 3 93: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System 83
Figure 3 94: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci 84
Figure 3 95: Robotic-assisted Versus Laparoscopic Sigmoid Resection 84
Figure 3 96: Prospective Investigation of Robotic Single-port System 85
Figure 3 97: Clinical Outcomes of Knee Replacement 86
Figure 3 98: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot 86
Figure 3 99: Robotic Arm Assisted Total Knee Arthroplasty 87
Figure 3 100: Outcomes of Robotic Total Hip Arthroplasty 87
Figure 3 101: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement 88
Figure 3 102: Prospective, Observational Registry of Renaissance-guided Spine Surgeries 89
Figure 3 103: Clinical Trial of Minimally Invasive Robotic Spine Surgery 89
Figure 3 104: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI) 90
Figure 3 105: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity 90
Figure 3 106: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries 91
Figure 3 107: A Post-Market Clinical Trial for Access and Visualization 92
Figure 3 108: Robotic-assisted Pedicule Screw Placement (ARASS) 93
Figure 4 1: Neurosurgery Robotic Assisted Surgery System Market, China, 2013 – 2023 (US$) 98
Figure 4 2: Neurosurgery Robotic Assisted Surgery System Market, China, 2013 – 2023 (CH¥) 99
Figure 4 3: Drivers and Limiters, Neurosurgery Robotic Assisted Surgery System Market, China, 2016 102
Figure 4 4: Leading Competitors, Neurosurgery Robotic Assisted Surgery System Market, China, 2016 104
Figure 4 5: Minimally Invasive Surgery Robotic Device Market, China, 2013 – 2023 (US$) 108
Figure 4 6: Minimally Invasive Surgery Robotic Device Market, China, 2013 – 2023 (CH¥) 109
Figure 4 7: Drivers and Limiters, Minimally Invasive Surgery Robotic Device Market, China, 2016 112
Figure 4 8: Robotic Radiosurgery Device Market, China, 2013 - 2023 116
Figure 4 9: Robotic Radiosurgery Device Market, China, 2013 - 2023 117
Figure 4 10: Drivers and Limiters, Robotic Radiosurgery Device Market, U.S., 2016 121
Figure 4 11: Leading Competitors, Robotic Radiosurgery Device Market, China, 2016 122
Figure 4 12: Drivers and Limiters, Robotic Assisted Orthopedic Surgery Market, China, 2016 126
Figure 4 13: Leading Competitors, Spinal Robotic Device Market, U.S., 2016 128
Figure 6 1: Press Release Summary 131
Figure 6 2: Press Release Summary 411

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology